Connecticut Senate Votes To Expand Psychedelics Pilot Program In Anticipation Of FDA Approval
Key Takeaway
The Connecticut Senate has passed a bill to expand a pilot program that’s meant to explore the therapeutic potential of psychedelics such as psilocybin and MDMA. The legislation sponsored by the Joint Committee on Public Health cleared the full Senate in a unanimous 35-0 vote on Wednesday. It now heads to the House of Representatives. […] The post Connecticut Senate Votes To Expand Psychedelics Pilot Program In Anticipation Of FDA Approval appeared first on Marijuana Moment.
What This Means for Cannabis Businesses
Tax developments like this directly impact the bottom line for every cannabis operator. With Section 280E creating effective tax rates above 70% for many businesses, any shift in federal tax policy - whether through rescheduling, court rulings, or IRS guidance - can mean the difference between profitability and closure. Cannabis business owners should work closely with a specialized CPA to understand how these changes affect their specific situation.
Connecticut Cannabis Market Overview
Connecticut launched recreational cannabis sales with a strong equity focus and publishes industry data through its open data portal. The state has approximately 300 active cannabis licenses and 1 licensed testing laboratories. There are 48 cannabis professionals serving Connecticut businesses on our directory, including CPAs, attorneys, and compliance consultants.
Related News
Cannabis MSOs Owe $1.6 Billion in Unpaid 280E Taxes as IRS Fights Back
IRS Disputes Cannabis Company's Challenge to 280E in Tax Court
Michigan Cannabis Sales Fall to Lowest Level in Two Years Under New Wholesale Tax
Congressional Research Service Questions Constitutionality of Cannabis Tax Section 280E
This analysis is based on reporting by Marijuana Moment. Read the original article. CannaBizGuide provides original commentary and analysis - this is not legal or tax advice.